These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36171714)

  • 1. Acute COVID-19 Presenting as Neurological Disease in a Pediatric Patient.
    Crowder F; Ebbert M; Neeley B; Mains N; McGuire S
    Clin Pediatr (Phila); 2023 May; 62(4):372-375. PubMed ID: 36171714
    [No Abstract]   [Full Text] [Related]  

  • 2. Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection.
    Llach CD; Vieta E
    Eur Neuropsychopharmacol; 2021 Aug; 49():119-121. PubMed ID: 33992951
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurological complications in COVID-19 patients from Latin America.
    Brucki SMD; Corazza LA; de Queiroz AP; Barros MP; Tatsch JFS; Riso IL; Batista NA; Manfroi G; Sawada LA; Batista LLR; Baldocchi MA; de Freitas JL; Aidar MB; Rocha MSG
    Brain; 2021 Apr; 144(3):e29. PubMed ID: 33347532
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial.
    Kullmann DM
    Brain; 2020 Oct; 143(10):2863. PubMed ID: 33103734
    [No Abstract]   [Full Text] [Related]  

  • 5. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement.
    Senel M; Abu-Rumeileh S; Michel D; Garibashvili T; Althaus K; Kassubek J; Otto M
    Eur J Neurol; 2020 Nov; 27(11):2378-2380. PubMed ID: 32781484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological Presentations of COVID-19: Characteristic Features in a Case Series of Hospitalized Patients from Abu Dhabi, UAE.
    Deeb A; Kumar PC; Sakrani N; Trehan RK; Papinenei VR
    Biomed Res Int; 2021; 2021():5822259. PubMed ID: 34423037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we sure that the neurological impact of COVID 19 in childhood has not been underestimated?
    Principi N; Esposito S
    Ital J Pediatr; 2021 Sep; 47(1):191. PubMed ID: 34537061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.
    Johansson A; Mohamed MS; Moulin TC; Schiöth HB
    J Neuroimmunol; 2021 Sep; 358():577658. PubMed ID: 34304141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuro-ophthalmologic complications of coronavirus disease 2019 (COVID-19).
    Gold DM; Galetta SL
    Neurosci Lett; 2021 Jan; 742():135531. PubMed ID: 33248158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Don't miss the diagnosis: neurological manifestations as presenting features of COVID-19.
    Madan A; Agarwal P; Ray S; Tyson B
    Clin Med (Lond); 2023 Nov; 23(Suppl 6):7. PubMed ID: 38182227
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 Infection: A Neuropsychiatric Perspective.
    Manolis TA; Apostolopoulos EJ; Manolis AA; Melita H; Manolis AS
    J Neuropsychiatry Clin Neurosci; 2021; 33(4):266-279. PubMed ID: 34280318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological infection with SARS-CoV-2 - the story so far.
    Solomon T
    Nat Rev Neurol; 2021 Feb; 17(2):65-66. PubMed ID: 33414554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus 2019: clinical and neuropathological aspects.
    Younger DS
    Curr Opin Rheumatol; 2021 Jan; 33(1):49-57. PubMed ID: 33229976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis.
    Schweitzer F; Kleineberg NN; Göreci Y; Onur OA; Franke C; Warnke C
    Curr Opin Neurol; 2021 Jun; 34(3):423-431. PubMed ID: 33709973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Authors Response: Adherence to Clear-cut Definitions Is Mandatory When Assessing Short- and Long-term Neurological Complications of COVID-19.
    Ishiyama H; Ishii J; Yoshimura H; Ohara N; Kohara N; Kawamoto M
    Intern Med; 2022 Aug; 61(15):2401. PubMed ID: 35022358
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurological complications in COVID-19 - a new diagnostic challenge.
    Vacaras V; Frunze S; Cordos MA
    J Med Life; 2022 Feb; 15(2):305-306. PubMed ID: 35419093
    [No Abstract]   [Full Text] [Related]  

  • 17. A WHO resolution on epilepsy and other neurological disorders.
    Winkler AS; Leonardi M; Michael BD; Abd-Allah F; Carroll W; Guekht A;
    Lancet Neurol; 2021 Mar; 20(3):171-172. PubMed ID: 33609470
    [No Abstract]   [Full Text] [Related]  

  • 18. Adherence to Clear-cut Definitions Is Mandatory When Assessing Short- and Long-term Neurological Complications of COVID-19.
    Finsterer J; A Scorza F
    Intern Med; 2022 Aug; 61(15):2399. PubMed ID: 35022351
    [No Abstract]   [Full Text] [Related]  

  • 19. [SARS-CoV-2 and neurological disorders: the revelance of biomarkers?].
    Bigot-Corbel E; Lanore A; Raulet C; Delorme C; Azulay JP; Lehmann S; Beaudeux JL; Beauvieux MC; Sapin V; Peoc'h K; Rucheton B;
    Ann Biol Clin (Paris); 2021 Feb; 79(1):7-16. PubMed ID: 33570039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercoagulability of COVID-19 and Neurological Complications: A Review.
    Moore P; Esmail F; Qin S; Nand S; Berg S
    J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106163. PubMed ID: 34763262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.